Cellectis S.A. (CLLS)
$1.26+0.80%Close
SELLCRISIS · day 20
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $127M
- Beta
- 3.00
- P/E (TTM)
- -2.15
- Short % float
- 0.41%
- Days to cover
- 2.3
- SI change
- -28.0%
- 1W
- -11.89%
- 1M
- -59.62%
- vs SPY 1W
- -13.05%
- vs SPY 1M
- -62.61%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CLLS?
- LOPJLB’s latest quantitative signal on Cellectis S.A. (CLLS) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CLLS in?
- Cellectis S.A. (CLLS) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Cellectis S.A. (CLLS) do?
- Cellectis S.A. is a biotechnology firm in the clinical development stage, concentrating on the creation of immuno-oncology therapies. These therapies harness gene-edited T-cells engineered to express chimeric antigen receptors, designed to specifically identify and eliminate malignant cells. Its operations are divided into two distinct divisions: Therapeutics and Plants. The therapeutic pipelin…